It all feels eerily similar to the lead up to the Elanco Option rejection in 2020. The share price in the months beforehand was down to these levels, but in anticipation of the Elanco deal coming to fruition it climbed quite rapidly to the 20c mark.
In 2022 I feel we are on more solid ground regarding the potential canine deal. The latest K9 data is irresistible and we have at least one potential suitor looking to negotiate on a commercial deal. The size and conditions are being determined but I think it must be getting close to a big reveal. I think that a Trading Halt in the next 30 days could be on the cards.
A satisfactory outcome on the doggies would erase the fears about funding all our other clinical trials.
All just my opinion, but wouldn't it be nice???
Good Luck to All
It all feels eerily similar to the lead up to the Elanco Option...
-
- There are more pages in this discussion • 686 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.5¢ | $345.5K | 2.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 170577 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 343944 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |